Myriad Genetics Inc (MYGN)

Return on assets (ROA)

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands -127,300 -263,300 -112,000 -27,200 -223,700
Total assets US$ in thousands 1,027,600 1,146,500 1,198,700 1,320,700 1,418,800
ROA -12.39% -22.97% -9.34% -2.06% -15.77%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $-127,300K ÷ $1,027,600K
= -12.39%

Myriad Genetics Inc's return on assets (ROA) has seen fluctuations over the years. In December 2020, the ROA was -15.77%, indicating that the company generated a net loss relative to its total assets during that period. There was a slight improvement in December 2021, with the ROA at -2.06%, suggesting a reduced net loss compared to the previous year.

However, the company's ROA deteriorated in December 2022 to -9.34%, signifying a decreased ability to generate profit from its assets. This negative trend continued in December 2023, with the ROA dropping further to -22.97%, indicating a significant decline in the company's profitability relative to its asset base.

In December 2024, there was a partial recovery as the ROA improved to -12.39%. While this is still negative, it shows a relative improvement compared to the previous year. Overall, Myriad Genetics Inc's ROA performance reflects a volatile financial position with periods of losses and challenges in effectively utilizing its assets to generate profits.